[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
March 27, 2013

Funding for Biomedical Research

Author Affiliations

Letters Section Editor: Jody W. Zylke, MD, Senior Editor.

Author Affiliations: Robert Wood Johnson Foundation Clinical Scholars Program (Dr Sun; gordonsu@med.umich.edu) and Department of Radiation Oncology (Dr Jagsi), University of Michigan, Ann Arbor; and Singapore Bioimaging Consortium, Agency for Science, Technology and Research, Singapore (Dr Steinberg).

JAMA. 2013;309(12):1228-1229. doi:10.1001/jama.2013.1331

To the Editor: Drs Moses and Dorsey1 suggested in their Viewpoint that biomedical researchers “must look to the private sector” to compensate for declining federal support. We believe that the limitations of private sector funding merit further consideration.

First, successful acquisition of funding from private sources does not guarantee that a researcher in the United States will remain in the country, where the downstream economic impact of biomedical laboratory activity can benefit local and regional communities.